Rather than conducting high-throughput assays covering thousands of genes to identify novel biomarkers, we specifically focused on analyzing a Tks4-centered interaction network, whose members’ roles have already been confirmed in colon cancer. This evidence concerns the gene SH3PXD2B and malignant colon neoplasm.